Welcome to our dedicated page for Inspira Tech SEC filings (Ticker: IINNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Clinical-trial updates, FDA timelines, and dilution clauses for Inspira Technologies often hide in dense 10-K tables and sudden 8-K releases. If you have searched “Where is Inspira Technologies’ quarterly earnings report 10-Q filing?” or tried decoding “Inspira Technologies insider trading Form 4 transactions,” you know how difficult it is to surface the data that moves this intravascular oxygenation pioneer. Stock Titan’s AI-powered summaries read every page the moment it hits EDGAR, translating biomedical jargon into clear insight so you can focus on decisions, not document hunting.
The hub streams every disclosure for the ordinary shares (IINN) and the warrants (IINNW) with real-time filing updates. Explore the cash-burn narrative inside the “Inspira Technologies annual report 10-K simplified,” follow HYLA blood-sensor cost trends through our “Inspira Technologies earnings report filing analysis,” or receive instant alerts for “Inspira Technologies Form 4 insider transactions real-time.” Need context on fresh capital? The platform highlights warrant exercises and shelf registrations in “Inspira Technologies 8-K material events explained.” Executive pay details are one click away via the “Inspira Technologies proxy statement executive compensation,” all annotated so you see option grants and vesting schedules at a glance.
Professionals use these insights to monitor executive stock transactions Form 4 before pivotal trial readouts, benchmark quarter-over-quarter R&D spend against regulatory milestones, and track segment revenue potential for disposable kits. Understanding Inspira Technologies SEC documents with AI removes complexity, letting you gauge clinical momentum, dilution risk, and insider sentiment in minutes.
FAQ
What is the current stock price of Inspira Tech (IINNW)?
The current stock price of Inspira Tech (IINNW) is $0.217 as of June 26, 2025.
What is the core focus of Inspira Technologies?
Inspira Technologies specializes in developing innovative respiratory support devices that offer a non-invasive alternative to mechanical ventilation, targeting acute respiratory failure.
How does Inspira Technologies differ from traditional mechanical ventilation?
Their devices utilize proprietary intravascular oxygenation technology and real-time blood monitoring, aiming to maintain adequate oxygen levels without the complications associated with invasive ventilation.
What are the primary technologies developed by the company?
The company’s portfolio includes the INSPIRA ART system, HYLA blood sensor for continuous monitoring, and the VORTX oxygenation delivery system, each designed to optimize patient care.
Which markets does Inspira Technologies serve?
Inspira operates in major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, focusing on advanced respiratory care.
How does the company enhance patient safety?
The technology is designed to reduce blood trauma and complications by using a non-invasive oxygenation process, allowing patients to remain awake and reducing risks typically seen with mechanical ventilation.
What is the company's approach to distribution and market penetration?
Inspira partners with established distributors and healthcare institutions, such as Glo-Med, to ensure efficient deployment and ongoing support in clinical settings.
What sets Inspira’s technology apart in the critical care industry?
Their innovative approach combines advanced nano-vesicle oxygenation with real-time blood monitoring, offering a flexible and safer option for respiratory support that minimizes invasive procedures.
Where can investors find more detailed information about Inspira Technologies?
Investors can review the company’s detailed disclosures and public filings for comprehensive insights into its technology, operational strategy, and market presence.